Globe Life Shares Fall Following Q3 Earnings Miss and Reduced Full-Year Guidance

Globe Life Inc. faced selling pressure late last month after releasing third-quarter financial results that fell short of market projections. Management lowered its full-year 2026 net operating income projection to between $15.35 and $15.65 per diluted share, down from the earlier band of $15.55 to $15.95 per share. The downward revision signaled that profitability challenges will continue through the remainder of the year.

For the third quarter, the insurer posted net operating income of $4.84 per share, missing consensus estimates that ranged from $4.87 to $4.91. While operating revenues rose 5.5% year over year to $1.61 billion, bottom-line results were hampered by rising expenses and weakening underwriting profitability. Total benefits and expenses climbed 11.5% to $1.15 billion, outpacing revenue gains. Overall insurance underwriting income dropped 4.2% from the prior-year period to $481.8 million.

Underwriting margins suffered primarily from an estimated $16 million underwriting loss at its Evry Health subsidiary. The company also absorbed approximately $7 million in excess Medicare Supplement expenses stemming from processing backlogs at the Centers for Medicare and Medicaid Services. Total premium revenue expanded 6.5% to $1.31 billion, supported by a 15.6% jump in health insurance premiums to $446.9 million. However, total life insurance underwriting margins fell 4.9% to $458.2 million, and direct-to-consumer life sales dropped 12%.

Following the earnings release, Wall Street analysts reassessed their outlooks. Piper Sandler downgraded the stock from Overweight to Neutral and reduced its price target from $200 to $165. The firm pointed to heightened volatility in quarterly earnings, arguing that the insurer has lost its dependable defensive standing within the life and health segment. Broader market sentiment has also contended with shareholder class-action litigation regarding policy procedures and sales practices at the American Income Life division.

Despite the margin compression, management continued its capital deployment plans by repurchasing roughly 1.1 million shares for US$185 million during the quarter and raising its buyback targets. The stock experienced volatile trading sessions following the announcement, slipping about 0.7% to US$168.41 on October 22, 2026, dropping to $163.50 during that morning, and subsequently falling 7.74% on October 23, 2026.